Tan Kevin 4
4 · Solid Biosciences Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Tan Kevin
CFO & Treasurer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2026-01-09+11,250→ 51,804 total - Sale
Common Stock
[F3][F2]2026-01-13$5.27/sh−5,704$30,060→ 46,100 total - Exercise/Conversion
Restricted Stock Units
[F1][F4]2026-01-09−11,250→ 11,250 total→ Common Stock (11,250 underlying)
Footnotes (4)
- [F1]Restricted stock units convert to common stock on a one-for-one basis.
- [F2]Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025 and November 28, 2025, respectively.
- [F3]This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan.
- [F4]The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Kevin Tan|2026-01-13